Tag Archives: Sutro Biopharma Inc

Sutro Biopharma Inc (STRO) Receives a Buy from Cowen & Co.

In a report released yesterday, Boris Peaker from Cowen & Co. maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report). The company’s shares closed on Friday at $11.20. According to TipRanks.com, Peaker is a 3-star analyst with

Sutro Biopharma Inc (STRO) Gets a Buy Rating from Cowen & Co.

Cowen & Co. analyst Boris Peaker maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report) yesterday. The company’s shares closed yesterday at $10.15. According to TipRanks.com, Peaker is a 4-star analyst with an average return of 3.3%

H.C. Wainwright Keeps a Buy Rating on Sutro Biopharma Inc (STRO)

H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report) today and set a price target of $18. The company’s shares closed yesterday at $10.15. Chattopadhyay said: “Valuation and risks to our investment

H.C. Wainwright Keeps Their Buy Rating on Sutro Biopharma Inc (STRO)

H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on Sutro Biopharma Inc (STRO – Research Report) today and set a price target of $18. The company’s shares opened today at $10.33. Chattopadhyay wrote: “Valuation and risks to our investment

Sutro Biopharma Inc (STRO) Received its Third Buy in a Row

After Piper Jaffray and JMP Securities gave Sutro Biopharma Inc (NASDAQ: STRO) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Boris Peaker maintained a Buy rating on Sutro Biopharma Inc today.